Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 12 Month Non-interventional (Observational), International, Multi-centre, Prospective Study to Evaluate the Bleeding Pattern of Ultra-low Dose Continuous Combined Hormone Replacement Therapy Containing 0.5 mg Estradiol and 0.1 mg Norethisterone Acetate (Eviana®)

NCT01076621 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.

NCT NCT01076621
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01076621 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 12 Month Non-interventional (Observational), International, Multi-centre, Prospective Study to Evaluate the Bleeding Pattern of Ultra-low Dose Continuous Combined Hormone Replacement Therapy Containing 0.5 mg Estradiol and 0.1 mg Norethisterone Acetate (Eviana®)
Lead sponsor
Novo Nordisk A/S
Phase
Observational
Overall status
Completed
Start date
May 31, 2010
Completion date
June 30, 2013
Enrollment
176 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

menopause, postmenopausal bleeding